A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2010

Conditions
Advanced MalignanciesTumors
Interventions
DRUG

Patupilone/EPO906

Trial Locations (4)

78229

Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science, San Antonio

South Texas Accelerated Research Therapeutics, San Antonio

92093-0987

University of California San Diego/Moores Cancer Center, La Jolla

87131-5636

Cancer Research and Treatment Center, Albuquerque

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY